Background:

Tumor necrosis factor (TNF; see MIM 191160) receptor-associated factors, such as TRAF7, are signal transducers for members of the TNF receptor superfamily (see MIM 191190). TRAFs are composed of an N-terminal cysteine/histidine-rich region containing zinc RING and/or zinc finger motifs; a coiled-coil (leucine zipper) motif; and a homologous region that defines the TRAF family, the TRAF domain, which is involved in self-association and receptor binding.

Applications:

ELISA, WB, IHC

Name of antibody:

TRAF7

Immunogen:

Synthetic peptide of human TRAF7

Full name:

TNF receptor-associated factor 7, E3 ubiquitin protein ligase

Synonyms：

RFWD1, RNF119

SwissProt:

Q6Q0C0

ELISA Recommended dilution:

1000-5000

IHC positive control:

Human colon cancer and Human gastric cancer

IHC Recommend dilution:

15-50

WB Predicted band size:

67 kDa

WB Positive control:

Jurkat cells

WB Recommended dilution:

200-1000